Integrative Physiology |
From the Institute of Physiology (B.F.P., D.L., L.V., U.P., S.-S.B.), Ludwig-Maximilians-University, Munich, Germany; Department of Physiology and Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (D.L., S.H., S.-S.B.), University of Toronto, Canada; Department of Biochemistry and Molecular Biology (A.H., S.S.), Virginia Commonwealth University School of Medicine, Richmond; and Institute of Human Genetics (H.J.B.), University of Cologne, Germany.
Correspondence to Steffen-Sebastian Bolz, MD, PhD, Department of Physiology and Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research, University of Toronto, 1 Kings College Circle, Medical Sciences Building, Room 3326, Toronto, Ontario, M5S 1A8, Canada. E-mail sts.bolz{at}utoronto.ca
Sphingosine-1-phosphate (S1P), which mediates pleiotropic actions within the vascular system, is a prominent regulator of microvascular tone. By virtue of its S1P-degrading function, we hypothesized that S1P-phosphohydrolase 1 (SPP1) is an important regulator of tone in resistance arteries. Hamster gracilis muscle resistance arteries express mRNA encoding SPP1. Overexpression of SPP1 (via transfection of a SPP1wt) reduced resting tone, Ca2+ sensitivity, and myogenic vasoconstriction, whereas reduced SPP1 expression (antisense oligonucleotides) yielded the opposite effects. Expression of a phosphatase-dead mutant of SPP1 (SPP1H208A) had no effect on any parameter tested, suggesting that catalytic activity of SPP1 is critical. The enhanced myogenic tone that follows overexpression of S1P-generating enzyme sphingosine kinase 1 (Sk1wt) was functionally antagonized by coexpression with SPP1wt but not SPP1H208A. SPP1 modulated vasoconstriction in response to 1 to 100 nmol/L exogenous S1P, a concentration range that was characterized as S1P2-dependent, based on the effect of S1P2 inhibition by antisense oligonucleotides and 1 µmol/L JTE013. Inhibition of the cystic fibrosis transmembrane regulator (CFTR) (1) restored S1P responses that were attenuated by SPP1wt overexpression; (2) enhanced myogenic vasoconstriction; but (3) had no effect on noradrenaline responses. We conclude that SPP1 is an endogenous regulator of resistance artery tone that functionally antagonizes the vascular effects of both Sk1wt and S1P2 receptor activation. SPP1 accesses extracellular S1P pools in a manner dependent on a functional CFTR transport protein. Our study assigns important roles to both SPP1 and CFTR in the physiological regulation of vascular tone, which influences both tissue perfusion and systemic blood pressure.
Key Words: Ca2+sensitization signal transduction transfection vascular smooth muscle myogenic response cystic fibrosis transmembrane regulator
Related Article:
Circ. Res. 2008 103: 231-233.
This article has been cited by other articles:
![]() |
D. Lidington, B. F. Peter, A. Meissner, J. T. Kroetsch, S. M. Pitson, U. Pohl, and S.-S. Bolz The Phosphorylation Motif at Serine 225 Governs the Localization and Function of Sphingosine Kinase 1 in Resistance Arteries Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1916 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-Phosphate: A Regulator of Arterial Lesions Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kauffenstein, A. Drouin, N. Thorin-Trescases, H. Bachelard, B. Robaye, P. D'Orleans-Juste, F. Marceau, E. Thorin, and J. Sevigny NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse Cardiovasc Res, August 20, 2009; (2009) cvp265v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sattler and B. Levkau Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc Res, May 1, 2009; 82(2): 201 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Igarashi and T. Michel Sphingosine-1-phosphate and modulation of vascular tone Cardiovasc Res, May 1, 2009; 82(2): 212 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ratjen Update in Cystic Fibrosis 2008 Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 445 - 448. [Full Text] [PDF] |
||||
![]() |
B. Levkau Sphingosine-1-Phosphate in the Regulation of Vascular Tone: A Finely Tuned Integration System of S1P Sources, Receptors, and Vascular Responsiveness Circ. Res., August 1, 2008; 103(3): 231 - 233. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |